Podcasts about Rvo

Monday on AOA, we start the show with a look at weather impacts in the markets and more with Darin Newsom, Senior Market Analyst at Barchart. In Segment Two, we get an update on the weather forecast for the week ahead across the country with DTN Meteorologist John Baranick. In Segment Three, we discuss ethanol provisions in the One Big, Beautiful Bill along with the recent RVO and SRE news with Geoff Cooper, President and CEO of the Renewable Fuels Association. Then we close out with ag news headlines in Segment Four.

Too busy to read the Lens? Listen to our weekly summary here! In this week's episode we discuss...Certain systemic medications for T2DM may increase DME risk, while others are protective, suggesting medication choice impacts retinal health.Daily low-dose valacyclovir reduces herpes zoster ophthalmicus-related recurrence at 18 months, supporting utility in long-term suppression.RVO incidence rose during the COVID-19 pandemic in South Korea among middle-aged adults, while RAO rates remained stable. Nanopore sequencing shows promise for uveitis diagnosis, detecting herpes viruses with up to 75% sensitivity and 100% specificity.

Tuesday on AOA, we start the show with a look at the cattle and grain markets with Kyle Bumsted from Allendale. In Segment Two, we discuss EPA's 2026-27 RVO news, 45Z and more with Donnell Rehagen, CEO of Clean Fuels Alliance America. In Segment Three, it's our first Tractor Zoom Tuesday as we discuss the latest trends in Row Crop Tractors, Row Crop Headers and more with Andy Campbell, Director of Insights at Tractor Zoom. Then we close the show in Segment Four with an update on kochia being found in northwest Missouri with Kevin Bradley, weed scientist with University of Missouri Extension.

Headlines on today's episode include:-Supreme Court still quiet on Roundup request-Idled biodiesel plants benefit from high RVO levels-Ongoing trade tensions adds volatility to U.S. trade-Beef export challenges to China continue-Sen. Ernst praises EPA for WOTUS goalSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Piter Mandemaker over tweedehands pakken en RVO subsidie by Haarlem105

The grain trade was generally higher on Tuesday as these markets are watching multiple factors including war risk in the Middle East, continued spillover from last week's RVO news and the lack of a weather story for the early growing season. Matt Bennett with AgMarket.net joins us for analysis and price perspective today. More online at https://www.agmarket.net. Are cattle futures FINALLY getting tired or was Tuesday's price action simply a case of fund liquidation driving the bus? Scott Varilek with Kooima Kooima Varilek joins us to discuss the cattle market action, cash activity and more. You can learn more online at https://www.kkvtrading.com.

Steven Johnson, retired Iowa State Extension farm management specialist; Ken Ericksen, Polaris Analytics and Consulting, trends in ag trade and barge transport

KABOOM! The EPA released their RVO mandate proposals at MUCH higher levels than trade expectations and the market reacted accordingly – 2 limit-up trading days for soybean oil! We'll also discuss the June WASDE, the NOPA May Crush report, and much more.

On the HAT Podcast Eric Pfeiffer and C.J. Miller have the news including a tool to help you make the most profitable nitrogen application decisions, and it's Indiana FFA State Convention week. HAT Chief Meteorologist Ryan Martin calls for warmer air this week and he will explain the rain possibilities today. Friday the soybean market led corn and wheat higher as world tensions heated up and EPA came through with a positive RVO proposal. Andy Eubank has settlements and analyst Brian Basting provides market commentary. It's all part of the #HATPodcast, made possible by First Farmers Bank & Trust - proudly serving local farms, families, and agribusiness for 140 years. Visit them online at FFBT.com to learn more.

Shawn Hackett discusses economic and commodity markets in this web-only feature discussing soybeans and the new RVO numbers, wheat, corn and weather concerns in the market.

Shawn Hackett discusses economic and commodity markets including RVO numbers, soybeans, wheat, corn, cotton, cattle and the feeder market along with comments on lean hogs.

Jeff Peterson with Heartland Farm Partners recaps Friday's trade. How would you summarize the corn and soybean markets at this time? What did you think of the proposed Renewable Volume Obligations from EPA that were announced this morning? What is the process for the RVO numbers to be finalized? Does the RVO affect the corn or soybean markets the most? Is Israel's attack on Iran having much to do with the corn and soybean markets being higher? How does the corn supply and demand look overall? What will it take to keep moving the corn and soybean markets higher?

This week Lucas and Mike discuss the WASDE, oil (RVO), and ECOs big payday. Listen in to a broad market overview today. 

Headlines on today's episode include: Ethanol groups react to 26-27 RVO mandates, Domestic, international demand increases for U.S. ethanol, Increasing raids creating uncertainty in ag labor sector, Don't get hung up on ag trade deficit, and Hail shreds corn and soybeans in north Iowa.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Rumors suggest the Environmental Protection Agency is preparing to announce RVO numbers for the renewable fuels Industry. Paul Winters with Clean Fuels Alliance America says the industry is united in its request for more biodiesel. The USDA's June WASDE report held few surprises for the commodity market. 

RFA President and CEO Geoff Cooper addresses a number of current ethanol industry issues, starting with RFA's participating in the upcoming Fuel Ethanol Workshop in Omaha and including comments on the One Big Beautiful Bill, E15 legislation in California, and the status of EPA's RVO proposal.

Markets reversed early gains as corn and soybeans weakened on trade, weather, and RVO uncertainty. Spring wheat and hogs firmed. Livestock faced profit-taking.

Soybeans gain on strong export data and RVO speculation, while corn and wheat weaken on good weather. Cattle volatile after false USDA screw worm report.

This week's Open Mic guest is Neil Caskey, CEO of the National Corn Growers Association. Caskey says last week's Make America Healthy Again report overshadowed the news of updates to the nation's farm programs and tax policy in the House of Representatives. Caskey is anxious to see the EPA's pending RVO announcement under the Renewable Fuel Standard and hopes Congress can finally approve year-round E-15 legislation. He says the nation's corn growers are willing to give President Trump's trade policy time to play out, but they hope the exercise leads to increased market access. 

It's a mixed bag of trade across grain and livestock futures as more RVO rumors swirl, impacting soybean oil, while cattle trade is finding solid support. Arlan Suderman, Chief Commodities Economist at StoneX, joins us to discuss in our Midday Commentary for Thursday, May 22nd, 2025.

Headlines on today's episode include: Assessing the Make America Healthy Again Commission report, Missouri farmer says MAHA report has no reassurance, Clean Fuels letter asks EPA to boost RVO levels, Fertilizer supplies are tight, Metapneumovirus exacts heavy toll on turkey industry, and R-CALF, Farmers Union urge cattle producers to file claims.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In deze podcast gaat Damaris samen met Annelies van Herwijnen in gesprek met Jurgen van der Heijden, jurist bij TNO en betrokken bij verschillende commons initiatieven, waaronder Constitutie voor de Commons en Energie Samen. Jurgen houdt zich bezig met het realiseren van commons op verschillende gebieden, waaronder energie en specifiek warmteprojecten.In deze podcast staan we stil bij de brede maatschappelijke waarde die door commons wordt gecreëerd en de nieuwe vitale vorm van de economie die door commons ontstaat. We bespreken de verschillende vormen van eigendom en de mogelijkheden van onverhandelbaarheid. En we staan stil bij de wijze waarop de gemeenschap de energietransitie kan versnellen en welk juridisch kader hierbij nodig is. Deze podcast is de tweede in een reeks van twee die we gemaakt hebben naar aanleiding van een project dat Economy Transformers uitvoerde in opdracht van RVO en het innovatieprogramma van de topsector Energie met juristen in de warmtetransitie gericht op de vraag wat het vernieuwen van het eigendom van grond en kapitaal kan betekenen en hoe je deze als commons het beste kunt inrichten.

In deze podcast gaat Damaris samen met Annelies van Herwijnen in gesprek met Ilonka Marselis. Ilonka is strategisch adviseur coöperatieve warmte bij Energie Samen. Energie Samen is de overkoepelende organisatie van energie coöperaties en vervult een belangrijke rol in het bundelen en verspreiden van kennis en ervaring in het opzetten en met elkaar operationeel hebben van energiegemeenschappen. Ilonka heeft zeer ruime ervaring met het werken in, met en vanuit gemeenschappen en de omgeving en overziet goed wat het behelst om een warmteproject op te zetten. In deze podcast bespreken we de dilemma's van warmteprojecten, waarom juist een gemeenschap bij uitstek de drijvende kracht achter een warmteproject kan zijn, hoe je dit in de praktijk kunt neerzetten voor wat betreft de juridische structuren en wat je daarbij kunt tegenkomen. Deze podcast is de eerste in een reeks van twee die we gemaakt hebben naar aanleiding van een project dat Economy Transformers uitvoerde in opdracht van RVO en het innovatieprogramma van de topsector Energie met juristen in de warmtetransitie gericht op de vraag wat het vernieuwen van het eigendom van grond en kapitaal kan betekenen en hoe je deze als commons het beste kunt inrichten.

The soy complex is leading the way higher at midday on Wednesday, is it due to more rumors that we could see RVO news out from the EPA later this week before the holiday weekend? Wheat and corn are also following to the upside while it is a mixed day in livestock trade. Arlan Suderman, Chief Commodities Economist at StoneX, joins us for analysis in our Market Talk Midday Commentary for Wednesday, May 21st, 2025.

Lots to discuss today! US planting pace (good), early season weather (good), tariff deals (good), Wheat Quality Council Tour (good), RUS/UKR peace deal (maybe?), and RVO mandates (still TBD)

Joe's Premium Subscription: www.standardgrain.comGrain Markets and Other Stuff Links-Apple PodcastsSpotifyTikTokYouTubeFutures and options trading involves risk of loss and is not suitable for everyone.0:00 Soybean Rally1:18 EPA and Bean Oil Selloff3:36 Kansas Wheat Tour6:28 Russia Wheat Update8:14 Tyson CEO and Cattle11:22 Ethanol Production

Clean Fuels Alliance America CEO Donnell Rehagen joins us to discuss the budget reconciliation and extension of 45Z as it applies to biodiesel, renewable diesel, and SAF plus the RVO timeline. National Corn Growers Association president Kenny Hartman, Jr. is busy planting but he takes some time out of his day to discuss biofuels issues, trade, 45Z, HFCS and more. Plus, United Soybean Board director Tony Mellenthin joins us for a new episode of the Soy Checkoff Check-in.See omnystudio.com/listener for privacy information.

Tuesday on AOA, powered by Cenex, we start the show with a look at this red-hot cattle market with Kyle Bumsted from Allendale. In Segment Two, we look at a new economic impact report commissioned by Clean Fuels Alliance America and get an update on 2026 RVO's with Kate Shenk, Director of Regulatory Affairs for Clean Fuels. In Segment Three, we get an update on the latest trends in the Meat Demand Monitor for April with Glynn Tonsor from Kansas State University. (Find the report here: https://agmanager.info/livestock-meat/meat-demand/monthly-meat-demand-monitor-survey-data) Then, we close the show discussing spring pests and Tick Awareness Week with Dr. Jim Fredericks from the National Pest Management Association.

2025 US planting is going strong and made good progress this past week. Also on this call: SBO stocks shenanigans, RVO rumors, and the latest updates in the trade wars

Laura & Ilona gingen samen naar de open dag van kwekerij Paard & Plant, onderdeel van kwekerij Arborealis. Ter plekke namen ze een aflevering op en spraken over vanalles!We spraken ook kort eigenaresse Sietske Metz van de kwekerij. Dat interview hebben we apart opgenomen en zetten we erin als bonus aflevering. Beloofde linkjesVogelwebcams van de vogelbescherming: https://www.vogelbescherming.nl/beleefdelenteMoestuindag Twickel: https://www.twickel.nl/agenda/agenda-moestuindagOpen keteldagen bij In dekoperen ketel: https://indekoperenketel.nl/kom-naar-de-open-keteldagen-2025/Wist je dat IVN: https://www.ivn.nl/wist-je-dat/Natuurcursus Leer de basis vanIVN: https://www.ivn.nl/aanbod/natuuracademie/ivn-natuurcursus-leer-de-basis/Info invasieve exotenInformatie over invasieve exoten: ⁠https://www.invasieve-exoten.info/nl/home-7/veel-gestelde-vragen-over-japanse-duizendknoop-en-reuzenberenklauw.htm⁠Verordening Invasieve Uitheemse Soorten: ⁠https://eur-lex.europa.eu/legal-content/NL/TXT/PDF/?uri=CELEX:32014R1143&from=BG⁠Info van het RVO: ⁠https://www.rvo.nl/onderwerpen/invasieve-exoten/algemene-regels#regels-invasieve-exoten⁠De Unielijst: ⁠https://www.nvwa.nl/onderwerpen/invasieve-exoten/unielijst-invasieve-exoten

This week's Open Mic guest is Steve Censky, CEO of the American Soybean Association.  Soybean farmers face surmountable challenges from low crop prices, high input costs and an uncertain future demand outlook. Censky hopes the current trade war is short-lived and brings worthy results. Censky says soybean farmers are watching closely the downsizing at USDA and holding out hope Congress can deliver a new farm bill this year. The EPA's pending RVO announcement could be the determining factor between profit and loss in 2025. 

Iowa Senator Charles Grassley said farm and nutrition spending could be amended in the budget reconciliation process. Grassley supports full year E15 sales and says either Congress or the EPA should raise RVO's for biodiesel. 

Overheid en ondernemen: kans of obstakel? RVO-directeur Frank de Jonge onthult hoe de overheid ondernemers helpt!

How can OCT angiography help retina specialists distinguish between retinal vein occlusion (RVO) and retinal artery occlusion (RAO) in patients who present without acute findings? Using real-world cases as a backdrop, Yasha Modi, MD, and Kat Talcott, MD, discuss Dr. Modi's approach to distinguishing RVO and RAO via OCT angiography and review which specific OCT angiography findings may indicate referral to cardiology. Later in the episode, they explore the utility and limitations of OCT angiography in patients with diabetic retinopathy.  This episode is supported by Zeiss Professional Education.

For 499 episodes of YMYW, Joe Anderson, CFP® and Big Al Clopine, CPA have been making fun of finance. On episode 500, we're celebrating The Top Funniest Moments From the Your Money, Your Wealth® Podcast, Vol. 2. (Check out episode 300 from way back in November of 2020 for Vol. 1.) For this episode, Executive Producer Andi Last compiled some rare, never before seen, can't-miss Derails, jokes, stories, screw-ups, and outtakes... from two talking heads sitting at a desk. We appreciate you following, watching, laughing, and commenting on YouTube or Spotify, but if you're listening in Apple Podcasts or another podcast app you'll laugh just as much. Access all the free financial resources and the episode transcript: https://bit.ly/ymyw-500 CALCULATE: A Financial Blueprint of your retirement readiness for free SCHEDULE: free financial assessment WATCH: Recipe for Retirement | Retirement Plans Explained on YMYW TV REQUEST: Ask Joe & Big Al for your Retirement Spitball Analysis SUBSCRIBE: YMYW on YouTube DOWNLOAD: more free guides READ: financial blogs WATCH: educational videos SUBSCRIBE: YMYW Newsletter 00:00 - Intro 00:51 - How to Ask Joe and Big Al On Air 01:20 - More Funnier 03:06 - Making Fun of Finance 08:06 - Don't Change a Thing 09:13 - Spitballing, Not Advice 09:41 - Watch Recipe for Retirement on YMYW TV 10:32 - Story Time: Al's Mid-life Crisis, Al's VW Rabbit, Joe's Travel Experiences, Hans' Paintings, Joe the Player, Joe the Dancer, Color Me Badd, Ricky Runs Fast, You're a 1099, FIRE, Retirement Planning Dinners, Movie Talk, RVO, Joe vs. the Holidays, Ice Skating 35:10 - Joe and Big Al... Are Human 39:56 - Calculate Your Financial Blueprint, Schedule a Free Financial Assessment 41:22 - More Joe and Big Al... Are Human 46:32 - Outro 47:05 - The YMYW Family 48:24 - The Biggest Derail Ever

Visit learnAMAstyle.com for free downloads in writing in medicine and the life sciences.    The FDA has approved blinatumomab (Blincyto) for treating adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in the consolidation phase. This bispecific T-cell engager (BiTE®) therapy targets CD19 surface antigens on B cells, allowing T cells to recognize and eliminate malignant B cells. The approval was based on the Phase 3 E1910 trial showing improved overall survival with blinatumomab plus chemotherapy compared to chemotherapy alone.   The FDA has approved roflumilast cream 0.15% (Zorvye) for treating mild to moderate atopic dermatitis (AD) in patients aged 6 years and older. This steroid-free, once-daily topical treatment is a selective, highly potent phosphodiesterase 4 (PDE4) inhibitor designed for long-term disease control. The approval was based on phase 3 studies showing significant improvements in disease clearance, itch reduction, and overall skin condition compared to the vehicle group.   The FDA has approved a new 6mg single-dose prefilled syringe for faricimab-svoa (Vabysmo), facilitating easier administration for neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). Faricimab-svoa is a VEGF and Ang-2 inhibitor, now available in a ready-to-use format. This approval provides an alternative to the existing single-dose vial and is granted to Genentech.   The FDA is set to decide on OX124, a high-dose naloxone nasal rescue medication designed to reverse opioid overdoses, with the PDUFA date set for July 15, 2024. Developed by Orexo, OX124 offers rapid absorption, high bioavailability, and enhanced stability, addressing the critical need for potent rescue medications due to the high rate of synthetic opioid overdoses. If approved, OX124's launch is anticipated later in 2024.   The FDA accepted an NDA for vonoprazan (Voquezna) tablets for treating heartburn associated with Non-Erosive gastroesophageal reflux disease (GERD) in adults, with the PDUFA date set for July 19, 2024. Vonoprazan is a potassium-competitive acid blocker (PCAB) offering an alternative to traditional proton pump inhibitors (PPIs). Non-Erosive GERD, affecting 38 million U.S. adults, is characterized by reflux-related symptoms without esophageal mucosal erosions, impacting quality of life with symptoms like heartburn and chest pain.  

Iowa Senator Charles Grassley says marking up a new farm bill should be a top priority for the Senate Ag Committee and says The EPA's delay on new RVO's will have consequences in rural America. 

What did a review of the AAO IRIS Registry reveal about the rates of retinal vein occlusion (RVO) during the COVID-19 pandemic? Moderator Katherine Talcott, MD, sits down with Phoebe Mellen, MD, and Kyle Kovacs, MD, to review the study's conclusion that RVO rates did not increase during the pandemic, discuss challenges about talking to patients seeking causality for an ocular phenomenon, and review the relative strengths and drawbacks of relying on the IRIS Registry. 

Uitblinken in de internationale zakenwereld? In deze aflevering nemen we een bijzondere focus op de Support International Business regeling, die ons toelaat om een blik te werpen op hoe subsidies een internationale doorbraak kunnen stimuleren vanuit Rijksdienst voor Ondernemend Nederland. Ontdek in deze aflevering: - Wat de grootste uitdagingen zijn die vrouwen ondervinden bij internationaal ondernemen en hoe deze overwonnen kunnen worden; - Hoe de support business regeling van RVO het beste benut kan worden door vrouwelijke ondernemers die hun producten internationaal willen testen; - Hoe belangrijk rolmodellen en mentorschap zijn bij het bevorderen van vrouwelijk leiderschap in de ondernemerswereld. PS. Kijk je liever het interview als video? ⁠⁠Bekijk deze video aflevering hier.⁠⁠ PS2. Meer weten over de Female Leaders Club? ⁠⁠Hier vind je meer informatie, ook over wie er lid zijn en wat we doen om elkaar te helpen groeien.⁠⁠ PS3. Lijkt het je leuk als gast in de Female Leaders Podcast te verschijnen? Meld je hier aan en wie weet nodigen we jou binnenkort uit in onze virtuele podcast studio: ⁠⁠https://forms.gle/9kBvnTfQEXLdhogm8 Interessante links: Stappenplan exporteren | KVK Zakendoen in België (rvo.nl) Zakendoen in de Verenigde Arabische Emiraten (VAE) (rvo.nl) Buitenlandnetwerk (rvo.nl) met meer over de collega's op de ambassades en NBSO's wereldwijd die klaar zitten om jou en andere ondernemers te helpen Webinar 25 april: Online spreekuur 'Kansen in Europa': ga in gesprek met onze adviseurs (rvo.nl)

CME credits: 1.00 Valid until: 14-11-2024 Claim your CME credit at https://reachmd.com/programs/cme/improving-outcomes-in-patients-with-rvo-tailoring-treatment/16626/ Dr. Carl Danzig, Director of Vitreoretinal Services and Retina Clinical Research of Rand Eye Institute in Deerfield Beach, Florida, and Dr. Arshad Khanani, Clinical Associate Professor at the University of Nevada in Reno, Nevada, will present key data about anti-VEGF therapies for retinal vein occlusion (RVO). Join the discussion on developing treatment protocols that use current therapies most effectively to improve outcomes and individualized treatment protocols for patients who are nonresponsive to first-line therapies and who require chronic treatment for macular edema.=

In the second episode of our four-part series, we delve into Sheriff John Mina's legislative push against the dangers of street racing, reckless driving and intersection takeovers with Lt. Mike Crabbe. Highlighting the growing menace these activities pose to public safety, the discussion covers proposed legal reforms aimed at escalating penalties, including turning second offenses into felonies and increasing fines for spectators, to deter such hazardous behavior and ensure safer streets for the community. (1:45): A brief history of OCSO's efforts to combat the problem (2:50): All of these illegal street activities are considered RVO's  (4:01): Recent trends we've seen (6:38): The role of social media with reckless vehicle operation (8:26): The problem, and the public's frustration, is widespread (10:10): The Sheriff's legislative proposal to combat the problem (16:10): Success stories from the last year of tackling the issue

De lijst wordt inmiddels langer dan het gemiddelde verlanglijstje aan Sinterklaas: Na VodafoneZiggo, Bol.com en de Nederlandse Loterij stopt nu ook de Rijksdienst voor Ondernemend Nederland (RVO) met adverteren op X. Dit in navolging van meerdere grote Amerikaanse bedrijven, zoals IBM, Walt Disney en Apple, die eerder al bekend maakten te stoppen met adverteren op het platform in verband met antisemitisme op X. RVO, dat onderdeel is van het ministerie van Economische Zaken en Klimaat laat weten dat het bereik van X onder hun doelgroep de afgelopen maanden al terugliep, dus ze verwachten niet dat de volledige stop enorme gevolgen zal hebben. Wel laat de overheidsinstantie weten dat ze X nog wel zullen gebruiken om vragen van klanten te beantwoorden en om eventuele storingen kenbaar te maken. Verder in deze tech-update:  DevTernity, online evenement voor developers is afgelast nadat verschillende sprekers en deelnemers zich terugtrokken toen bleek dat de organisator nep profielen van vrouwelijke sprekers had gebruikt om net te doen of er sprake was van een hele diverse line-up. See omnystudio.com/listener for privacy information.

Please visit answersincme.com/MUP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in ophthalmology discusses the importance of early detection and referral of patients with retinal vein occlusion (RVO), as well as a personalized and multidisciplinary approach to management. Upon completion of this activity, participants should be better able to: Recognize the rationale for early detection of RVO; Describe the appropriate processes for timely referral of patients with RVO; and Outline strategies for personalized, multidisciplinary management of patients with RVO.

In deze podcast zijn de Founding Fathers van GLUE Amsterdam te gast in De Interieur Club Podcast: ontwerpers ruud van oosterhout en Robert Bronwasser. We gaan het natuurlijk hebben over GLUE maar ook over de weg die zij bewandeld hebben met mooie lessen en verhalen! Ruud van Oosterhout en zijn team werken aan een uitgebreide portfolio van interior design projecten waaronder high-end appartementen en villa's, resorts en retail. Daarnaast ontwerpt Ruud van Oosterhout zijn eigen meubelcollectie, tapijten, porselein, glas en geeft hij les aan de Design Academie Eindhoven . RvO design studio en showroom is gevestigd in een prachtig pand midden in het museum district van Amsterdam pal naast het Rijksmuseum. Robert Bronwasser brengt passie, creativiteit, gezond verstand en 25 jaar ervaring samen in functioneel design met een eigen gezicht. In 1992 studeerde hij Cum Laude af als Industrieel Ontwerper aan de TU Delft. Vandaag de dag is Robert Bronwasser een erkend ontwerper die samenwerkt met creatieve merken en labels van naam. Zijn werk is bekroond met diverse designprijzen.De vierde editie van GLUE is van 14 tot en met 17 september 2023. Host: ⁠Mark Timo⁠ De Interieur Club is hét inspiratieplatform voor de interieurprofessional. De Interieur Club is jouw partner om samen aan je interieurbedrijf te bouwen. Wij bieden de wekelijkse interieurpodcast, De Interieur Club Academie met cursussen, netwerkborrels, inspiratieblogs en masterclasses zodat jij jezelf kan ontwikkelen. Iedere week een inspirerend en informatief gesprek voor de interieurprofessional. Kijk voor meer informatie en de agenda onze website: ⁠www.deinterieurclub.com

EPA announced a final rule Wednesday to establish renewable volume obligations (RVO) and associated percentage standards for cellulosic biofuel, biomass-based diesel (BBD), advanced biofuel, and total renewable fuel for 2023–2025. The industry had been waiting for this final rule after a disappointing proposed rule months ago. Stakeholders’ reaction to the final rule was consistently negative,... Read More

Wednesday's AOA began with a look at the powerful rally in the grain markets with Jacob Burkes of AgMarket.net. Jeff Johnston, Lead Economist for Communications at CoBank provided an update on federal investment in rural broadband rollout. Tanner Beymer, Senior Director, Government Affairs at NCBA discussed the recent House Appropriations Bill for Agriculture and what changes it could require. We closed the episode with Paul Winters, Director of Communication at Clean Fuels Alliance America with an update on the EPA's RVO release.

In this podcast, expert clinicians will discuss long-acting injectables in RVO management.

According to a new study that was published in the Nature medical journal, it turns out that people who received the mRNA-based Covid vaccines have an increased risk of a serious eye problem. Specifically, the Taiwanese researchers behind this paper found that the risk of Retinal Vascular Occlusion (RVO) increased significantly after a person received a covid vaccine. For your reference, RVO occurs when a blood clot blocks the blood vessels which carry blood to and from the retina. This lack of blood flow can, among other things, cause sudden vision loss. And, for a while now, it's been known that RVO is more likely to occur in people with things like diabetes, high blood pressure, high cholesterol levels, or other related health problems that affect the normal flow of blood. However, we can now add to that list: those who took an mRNA injection. ⭕️ Sign up for our NEWSLETTER and stay in touch

According to a new study that was published in the Nature medical journal, it turns out that people who received the mRNA-based Covid vaccines have an increased risk of a serious eye problem. Specifically, the Taiwanese researchers behind this paper found that the risk of Retinal Vascular Occlusion (RVO) increased significantly after a person received a covid vaccine. For your reference, RVO occurs when a blood clot blocks the blood vessels which carry blood to and from the retina. This lack of blood flow can, among other things, cause sudden vision loss. And, for a while now, it's been known that RVO is more likely to occur in people with things like diabetes, high blood pressure, high cholesterol levels, or other related health problems that affect the normal flow of blood. However, we can now add to that list: those who took an mRNA injection. ⭕️Watch in-depth videos based on Truth & Tradition at Epoch TV

Ingvald is a hands-on, award-winning design leader who has helped innovate and commercialize over 100 products, services and experiences across a variety of industries. Ingvald is currently the Sr. Director of User Experience at RVO health, a joint venture between United Healthcare and Red Ventures. Previously, as the co-founder and partner at Pull, he led the Strategy practice. He leverages his multicultural and cross disciplinary background to help companies innovative, and has built cross disciplinary teams and implemented User Centered Design methodologies at companies such as BMW Designworks, Optum and PepsiCo. Ingvald is a graduate of the ArtCenter College of Design with a degree in product design and holds numerous awards and over 30 international patents. He has held speaking engagements at Harvard, USC and Pratt, judged design awards and mentored at UCLA.